-
Hymon® Mycobacterium Tuberculosis Detection Kit
This kit uses RT-PCR for in vitro detection of Mycobacterium tuberculosis in nasopharyngeal and/or oropharyngeal swab, sputum and bronchoalveolar lavage fluid samples. Test results may serve as a reference for clinical evaluation of Mycobacterium tuberculosis infection.
Based on high-efficiency enzymatic processing technology, sample processing and purification are simultaneously completed in one tube to release and stabilize the pathogen nucleic acid.
The test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
-
Hymon® BCR-ABL Tyrosine Kinase Gene Detection Kit
This kit uses RT-PCR to detect breakpoint cluster region-abelson leukemia (BCR-ABL) fusion gene in plasma or formalin-fixed paraffin-embedded tissue (FFPE). Test results may serve as a reference for clincial evaluation fo defined BCR-ABL fusion gene in chronic myeloid leukemia patients. Confirmed mutation: recommended therapies include imatinib, treatment options and drug efficacy evaluation.
Based on high-efficiency enzymatic processing technology, the test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
-
Hymon® IDH1, IDH2 and FLT3 Gene Mutation Detection Kit
This kit uses RT-PCR to detect human isocitrate dehydrogenase (IDH1 and IDH2) and FMS-like tyrosine kinase 3 (FLT3) gene mutations in plasma or formalin-fixed paraffin-embedded tissue (FFPE). Test results may serve as a reference for clinical evaluation of defined IDH1, IDH2 and FLT3 gene mutations in acute myeloid leukemia (AML) patients. Confirmed mutation: recommended medications include ivosidenib, enasidenib, gilteritinib, midostaurin
The test uses specific gene sequences as PCR target regions. Human genomic sequence is used as internal quality control.
-
Hymon® BRAF Gene Mutation Detection Kit
This kit uses RT-PCR to detect v-raf murine sarcoma viral oncogene homolog B1 (BRAF) gene mutations in plasma or formalin-fixed paraffin-embedded tissue (FFPE) samples. Test results may serve as a reference for clincial evaluation of defined BRAF gene mutations in melanoma and non-small-cell lung cancer (NSCLC) patients. Confirmed mutation: recommended medications include dabrafenib, vemurafenib, trametinib, etc.
Based on high-efficiency enzymatic processing technology, the test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
-
Hymon® RET Gene Mutation Detection Kit
This kit uses RT-PCR to detect rearranged during trasfection (RET) M918T, C634Y, and C634R mutations in plasma or formalin-fixed paraffin-embedded tissue (FFPE). Test results may serve as a reference for clinical evaluation of defined human RET gene mutations in targeted drug use and drug resistance for non-small cell lung cancer (NSCLC). Confirmed mutation: recommended medications include pratinib, selpercatinib, etc.
Based on high-efficiency enzymatic processing technology, the test uses specific gene sequences as PCR targets. Human geonomic sequence is used as internal quality control.
-
Hymon® MET Gene Mutation Detection Kit
This kit uses RT-PCR to detect human mesenchymal-epithelial transition factor (MET) gene mutations in peripheral blood or formalin-fixed paraffin-embedded tissue (FFPE) samples. Targeted medication for non-small cell lung cancer (NSCLC). Confirmed mutation: recommended medications include savolitinib, gumetinib, etc.
Based on high-efficiency enzymatic processing technology, the test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
-
Hymon® ROS1 Fusions Gene Detection Kit
This kit uses RT-PCR to detect recombinant c-ros oncogene 1 (ROS1) fusion gene in plasma or formalin-fixed paraffin-embedded tissue (FFPE). Test results may serve as a reference for clinical evaluation of defined ROS1 fusion gene in non-small-cell lung cancer (NSCLC) patients. Confirmed mutation: recommended medications include emtricinib, crizotinib, ceritinib, etc.
Based on high-efficiency enzymatic processing technology, the test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
-
Hymon® EML4-ALK Fusion Gene Detection Kit
This kit uses RT-PCR to detect echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK) fusion gene in plasma or formalin-fixed paraffin-embedded tissue (FFPE). Test results may serve as a reference for clinical evaluation of defined EML4-ALK fusion gene in non-small-cell lung cancer (NSCLC) patients. Confirmed mutation: recommended medications include crizotinib, ceritinib, alectinib, etc.
Based on high-efficiency enzymatic processing technology, the test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
-
Hymon® EGFR Gene Mutation Detection Kit
This kit uses RT-PCR to detect epidermal growth factor receptor (EGFR) gene mtuation in plasma or formalin-fixed paraffin-embedded tissue (FFPE). Test results may serve as a reference for clinical evaluation of defined EGFR gene mutations in non-small-cell lung cancer (NSCLC) patients. Confirmed mutation: recommended medications include gefitinib, afatinib, dacomitinib, erlotinib, osimertinib, etc.
The test uses specific gene sequences as target regions. Human genomic sequence is used as internal quality control.
-
Hymon® KRAS Gene Mutation Detection Kit
This kit uses RT-PCR to detect kirsten rat sarcoma viral oncogene (KRAS) gene mutations in formalin-fixed paraffin-embedded tissue (FFPE). Test results may serve as a reference for clinical evaluation of defined KRAS gene mutation in non-small cell lung cancer (NSCLC) and colorectal cancer patients. Confirmed mutation: the patient is not suitable to use cetuximab or panitumumab.
The test uses specific gene sequences as PCR target regions. Human genomic sequence is used as internal quality control.
-
Hymon® MULTONE™ Monkeypox Test Kit
Hymon® provides a quantitative PCR MULTONETM Monkeypox Test Kit for quick and sensitive detection of Monkeypox virus. This kit can detect specific nucleic acid fragments of the virus with Hymon’s innovative “one-step” method as fast as 30 minutes from sample to results. The reagent uses the company’s unique MoLock and DIDC technology, suitable for accurate diagnosis of related diseases. It has the characteristics of fast detection, high sensitivity, and high specificity, and is compatible with conventional fluorescent PCR platforms.
-
Nucleic Acid Extraction Kit (Solid Phase Matrix Method)
The reagent can be used to purify nucleic acids in whole blood, swab samples and other body fluid samples. This product mainly provides purified high-quality nucleic acid for downstream nucleic acid amplification experiments or other enzyme kinetics experiments.
